The Netherlands Cancer Institute partners with Kaiku Health to develop the next generation of digital patient monitoring and management
The Netherlands Cancer Institute (NKI), an internationally acclaimed Comprehensive Cancer Center, collaborates with Kaiku Health, an innovator in the field of digital therapeutics for oncology, to develop the next generation of patient-reported outcomes and symptom management. The collaboration is part of a larger clinical trial named NADINA, a phase III trial for neoadjuvant immunotherapy for stage 3 melanoma, where NKI is the principal investigator.
#r&d
#platform